Freedom highlighted stocks with upside potential of up to 59%

Innovative Aerosystems (IA) and Alcoa (AA) have the highest estimated upside potential among the active recommendations in Freedom Broker investment review No.355. The target prices imply gains of 58.57% and 50.66%, respectively, versus the quotes cited in the Oct. 9 issue.

Six active recommendations

The selection includes companies in the aviation industry, metals, healthcare, utilities, retail and technology.

For Innovative Aerosystems (IA), the target price is $31, which is 58.57% above the $19.60 price indicated in the review. For Alcoa (AA), the benchmark is set at $64 versus a price of $42.50, implying upside potential of 50.66%.

Intuitive Surgical’s (ISRG) target price is $540 versus $414.50 in the review. The estimated upside is 30.27%. For Northwest Natural Holding (NWN), the target is $57 versus a price of $47.80, implying upside of 19.30%.

For Walmart (WMT), analysts set a target price of $124, 14.64% above the $108.20 level. For Alphabet (GOOGL), the benchmark is $400 versus $350.50, corresponding to upside potential of 14.12%.

All six stocks carry a “Buy” rating. The prices and estimated upside are based on data from the Oct. 9 review and do not reflect current quotes.

What supports the investment ideas

Earlier, Freedom explained the appeal of Innovative Aerosystems by an increase in orders and an expansion of its product lineup. The aviation equipment manufacturer develops solutions for commercial, business and military aviation. Among the risks, analysts pointed to the integration of acquired businesses and possible project delays.

Regarding Intuitive Surgical, Freedom highlighted improving business profitability. The company manufactures robotic surgical systems.

Target prices do not guarantee returns

The selection separates active ideas from closed positions. In particular, recommendations for Alibaba and Nike were marked as completed after stop-loss levels were triggered on Oct. 2.

Estimated upside shows the difference between the price in the review and the analyst’s target. It changes along with quotes and does not mean guaranteed growth.

This is not an individual investment recommendation.